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INTRODUCTION 
One of the most feasible approaches for achieving a 
prolonged and predictable drug delivery in the GI tract is 
to control the gastric residence time (GRT), by using 
gastro retentive dosage forms (GRDFs). GRDF’s can 
remain in the gastric region for several hours and hence 
prolong the gastric residence time of drug. GRDF’s offer 
several advantages over immediate release dosage form, 
including the minimization of fluctuations in drug 
concentration in plasma, and at the site of action over 
prolonged periods of time, resulting in optimized 
therapeutic efficiencies and reduce the side effect, 
reduction of total dose administered, (while providing 
similar therapeutic effect) and reduction of 
administration frequency, leading to improved patient 
compliances. Various approaches have been pursued to 
increase the retention of an oral dosage form in the 
stomach among which low density floating drug delivery 
systems forms major drug delivery devices. These 
systems maintain a density of less than 1.004 gm/cm
3
 
which makes them float on the gastric contents. The 
various types of buoyant preparation include hollow 
microsphere (micro balloons), granules powder, capsule, 
tablet (pills) and laminated films.
1-3 
Hollow microsphere floats immediately upon contact 
with gastric fluid and gives promising approaches for 
increasing the bioavailability of drugs with absorption 
windows in upper small intestine and stomach. However, 
immediate floating can only be achieved, when the 
density of the device is lower than gastric fluid.
4-6 
Glipizide is a second-generation oral sulfonylurea 
hypoglycemic agent used in lowering the blood sugar 
levels in patients with non-insulin dependent diabetes 
mellitus. Gastrointestinal absorption is uniform, rapid 
and essentially complete with peak plasma concentration 
occurring 1 to 3 hrs after a single dose. It is extensively 
bound to plasma proteins and a half-life of 
approximately 2 to 4 hrs. In order to maintain therapeutic 
plasma concentration, the drug must be administered 
frequently by oral route in divided doses which leads to 
fluctuations in plasma drug levels.
7-9 
To overcome inherent drawbacks associated with 
conventional dosage forms of Glipizide, an attempt is 
being made to develop an alternative drug delivery 
system in the form of floating microspheres. 
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ABSTRACT 
Recently, several technical advancements have led to the development of several novel drug delivery systems (NDDS) that 
could release the active ingredient over an extended period of time and further deliver the drug directly to the site of action, 
thus minimizing or eliminating side effects. In the present study 8 formulations of Glipizide floating microspheres were 
prepared using varying concentrations of Eudragit RS100 and HPMC by Emulsification solvent diffusion method. The floating 
microspheres were evaluated for percentage yield, drug loading, in-vitro buoyancy behavior as well as drug polymer 
compatibility, scanning electron microscopy, and in-vitro drug release. The micrometric properties were found to be good and 
scanning electron microscopy shows that the microspheres were spherical with smooth surface and a hallow cavity inside 
microspheres. The practical yield was found to be in the range of 69.88-95.98% and with a particle size range of 617.19-882.75 
µm. The percent entrapment is about 60.24% to 90.68% and percent drug loading is about 18.21 to 30.85% which decreased 
with increase in HPMC concentration in the formulations. The microspheres with high concentrations of Eudragit showed 
higher buoyancy. The in-vitro release was slow and extended to more than 12 hours which increased with significant increase 
in HPMC concentration but decreased in buoyancy character. Release obeys zero order kinetics and the drug release was 
diffusion controlled. Hence it can be concluded that the floating microsphere of Glipizide may prolong drug release thereby 
improving bioavailability and enhance opportunity of absorption in stomach. 
Keywords: Glipizide, Floating Microspheres, Controlled release 
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MATERIALS & METHODS 
Preparation of Floating Microspheres of 
Glipizide:
10,11 
For present study, acrylic polymer Eudragit combined 
with Hydroxy Propyl Methyl Cellulose is used with the 
active ingredient for preparation of floating microspheres 
(Table 1). 
Glipizide floating microspheres were prepared using 
varying concentrations of Eudragit RS100 and HPMC by 
Emulsification solvent diffusion method. The drug to 
polymer ratio used to prepare the different formulations 
was 1:7. The drug and polymer mixture is dissolved in a 
mixture of ethanol (8 ml) and dichloromethane (8 ml) 
and dropped into 0.75% polyvinyl alcohol solution (200 
ml). The solution was stirred with a propeller-type 
agitator at 40° C temperature for 1 hour at 300 rpm. The 
formed floating microspheres were passed through sieve 
no 12 and washed with water and dried at room 
temperature in a desiccator. 
 
Table 1: Formulation Design of Glipizide Floating Microspheres 
Sl. No Code Glipizide (mg) Eudragit RS100 (mg) HPMC (mg) 
1 F1 100 700 0 
2 F2 100 600 100 
3 F3 100 500 200 
4 F4 100 400 300 
5 F5 100 300 400 
6 F6 100 200 500 
7 F7 100 100 600 
8 F8 100 0 700 
 
Evaluation of Drug Loaded Floating Microspheres: 
Percentage Yield:
12 
The prepared microspheres were collected and weighed 
from different formulations. The measured weight was 
divided by the total amount of all nonvolatile 
components which were used for the preparation of the 
microspheres. 
% Yield = Actual weight of product/ Total weight of 
drug and polymer x 100 
Particle size analysis:
13-15 
The sizes of floating microspheres were measured by 
using an optical microscope, and the mean particle size 
was calculated by measuring nearly 200 particles with 
the help of a calculated ocular micrometer. 
Buoyancy behavior of Floating microsphere:
16 
The floating ability was determined using USP 
dissolution tester apparatus II (Paddle method). About 
100 mg of the floating microsphere were placed in 0.1 N 
Hcl (300 ml) containing 0.02% of Tween 20. The 
mixture was stirred with paddle at 100 rpm. The layer of 
buoyant microspheres was taken out and separated by 
filtration at 1, 2, 4 and 6 hours. The collected 
microspheres were dried in a desiccator over night. The 
percentage of microspheres was calculated by the 
following equation: 
% Floating = Weight of floating microspheres/ Initial 
weight of microspheres x 100 
Encapsulation Efficiency and Drug Loading:
17,18 
The amount of drug encapsulated in floating 
microspheres was determined by sonicating known 
amount of microspheres in ethanol for 15 min and 1 ml 
of this solution was withdrawn and diluted to 50 ml with 
0.1 N Hcl. This solution was assayed for drug content by 
UV spectrophotometer at 276 nm. Calculating this 
concentration with the dilution factor we get the 
percentage drug content. 
a. Encapsulation Efficiency was calculated as: 
EE (%) = [Actual Drug Content / Theoretical Drug 
Content] X 100 
b. Drug Loading was calculated as: 
DL (%) = [Actual Drug Content / Weight of 
Powdered Microspheres] X 100 
Scanning Electron Microscopy: 
Sample was fixed on carbon tape and fine gold sputtering 
was applied in a high vacuum evaporator. The 
acceleration voltage was set at 30KV during scanning. 
Microphotographs were taken on different magnification 
and higher magnification (500X) was used for surface 
morphology. 
Drug Polymer Interaction (FT-IR) Analysis:
19 
The Fourier transform infra-red analysis was conducted 
for the analysis of drug polymer interaction and stability 
of drug during microencapsulation process. Fourier 
transform infra-red spectrum of pure Glipizide, Eudragit 
RS 100, HPMC, Physical mixture and floating 
microspheres (formulation) were recorded. 
In-vitro Release Studies:
20-23 
A weighed amount of floating microspheres equivalent 
to 100 mg Glipizide were dispersed in 900 ml of 0.1 N 
Hcl (pH 1.2) maintained at 37 ± 0.5°C and stirred at 100 
rpm. One ml of sample was withdrawn at predetermined 
intervals and was suitably diluted with 0.1 N Hcl and 
analyzed spectrophotometrically at 276 nm to determine 
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the concentration of drug present in the dissolution 
medium. 
RESULTS & DISCUSSION: 
In the current research, floating microspheres loaded 
with Glipizide were developed and evaluated. 
IR Studies 
The physical mixture showed identical spectrum with 
respect to the spectrum of the pure Glipizide, indicating 
there is no chemical interaction between the drug 
molecule and polymers used. (Fig 1-5) 
 
 
Fig 1: FTIR spectrum of pure Glipizide 
 
 
Fig 2: FTIR spectrum of Eudragit 
 
 
Fig 3: FTIR spectrum of HPMC 
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Fig 4: FTIR spectrum of physical mixture of Drug + Eudragit + HPMC 
 
 
Fig 5: FTIR spectrum of Formulation F4 
 
Percentage Yield: 
For different formulations percentage yield was 
calculated by weighing the microspheres after drying. 
The percentage yield of floating microspheres was in 
range of 54.35 - 82.87% (Table 2 & Fig 6). 
Particle Size Analysis: 
The mean particle size of floating microspheres was in 
range of 617.42-882.75 μm (Table 2). As the particle size 
increased the rate of release decreased showing good 
controlled release nature along with optimum buoyancy 
character. 
Percent Encapsulation Efficiency and Percent Drug 
loading: 
The drug entrapment efficacies and percent drug loading 
of the prepared microspheres were in the range of 60.24 
to 90.68% w/w and 18.21 to 30.85% (Table 2 & Fig 6). 
Drug entrapment efficacy and drug loading slightly 
decreased with increased HPMC content and decreased 
Eudragit ratio in microspheres. This can be attributed to 
permeation nature of HPMC that could facilitate the 
diffusion of part of entrapped drug to surrounding 
medium during preparation of hollow microspheres. 
Buoyancy Character of Microspheres: 
Floating ability was found to be altered according to 
Eudragit and HPMC ratio. F1-F4 formulations showed 
best floating ability with 80.64 to 93.74% and 
formulations F5-F8 showed less floating ability of 58.39 
to 71.82% in 6 hours (Table 2). The floating ability of 
microspheres is decreased by increasing the HPMC ratio 
in the formulations. 
 
Table 2: Particle Size, Percentage Yield, % Encapsulation, % Drug Loading 
Code % Yield Particle Size (µm) %Encapsulation % Drug Loading % Buoyancy 
F1 95.98 882.75 90.68 30.85 93.74 
F2 90.68 841.19 89.13 28.69 91.32 
F3 85.36 799.84 86.64 27.46 88.19 
F4 81.92 768.28 81.39 25.13 80.64 
F5 76.38 747.31 70.56 20.89 71.82 
F6 74.13 740.12 68.16 19.22 69.95 
F7 71.65 681.86 65.81 19.01 62.17 
F8 69.88 617.19 60.24 18.21 58.39 
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Fig 6: % Yield, % Encapsulation Efficiency & % Drug Loading  
 
Scanning Electron Microscopy: 
Surface morphology of the optimized formulation showed a smooth surface and small hollow cavity present inside the 
microspheres which is responsible for their floating behavior (Fig 7). 
 
 
Fig 7: SEM Photograph of Mucoadhesive Microspheres (F4) 
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In-vitro release studies: 
The In vitro release studies of mucoadhesive 
microspheres were carried out in 0.1 N Hcl as a 
dissolution medium. Eudragit RS100 is less soluble in 
acidic pH, therefore release of drug in 0.1 N Hcl was 
generally low. The release rates of formulations F1-F8 
after 12 hours were found to be 39.78%, 50.14%, 
63.67%, 74.96%, 93.81%, 94.29%, 95.65% and 96.82% 
respectively. The release was slow and incomplete for 
the first four formulations (F1-F4) containing more 
amount of Eudragit than HPMC. But they showed good 
buoyancy character. Formulations F5-F8 containing more 
amount of HPMC than Eudragit showed complete drug 
release with less buoyancy character. Finally formulation 
F4 is considered as the best formulation with an 
appropriate balance between buoyancy and drug release 
rate. (Table 3 & Fig 8) 
Table 3: In vitro release of floating microspheres in 1.2 
pH buffer  
Formulation 
% Drug release at 12
th
 hour in 0.1 N 
Hcl 
F1 39.78 
F2 50.14 
F3 63.67 
F4 74.96 
F5 93.81 
F6 94.29 
F7 95.65 
F8 96.82 
 
 
 
Fig 8: In-vitro dissolution profile of floating microspheres of Glipizide in pH 1.2 buffer 
 
CONCLUSION: 
By studying all the experimental results floating 
microspheres encapsulated with Glipizide can be 
successfully formulated by emulsification solvent 
diffusion method. By incorporating hydrophilic polymer 
such as HPMC in the shell of microspheres, the rate of 
drug release can be enhanced. Characteristic property of 
floating microsphere includes high buoyancy and 
sufficient release of drug in gastric contents. Formulation 
F4 showed best appropriate balance between buoyancy 
and drug release rate, which can be considered as a best 
fit for floating microspheres. 
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